BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2014
View Archived Issues
Combination of GPR40 agonist and GLP-1 agonist improves glucose control in type 2 diabetes
Read More
WNT-974, a porcupine inhibitor targeting Wnt signaling in clinical testing
Read More
Candidate antidepressant mGlu2 and 3 receptor antagonists identified at Lilly
Read More
Development of a mouse model mimicking human ulcerative colitis
Read More
Paradigm to conduct genomic analysis to predict response to Tesaro's TSR-011
Read More
NuSirt Biopharma initiates phase II study of metformin/leucine combinations
Read More
Cardiac-selective sodium current inhibitor discovered at Gilead Sciences
Read More
ENSPIRIT trial of custirsen passes interim futility analysis
Read More
Heptares uses StaR platform to derive orexin receptor antagonists
Read More
Antitope and University College London to generate fully humanized antibodies
Read More
AbbVie begins phase I study of ABT-957 in subjects with Alzheimer's disease
Read More
Genentech begins phase I study of MOXR-0916 in locally advanced or metastatic solid tumors
Read More
Novel anti-HCV MAbs disclosed by Genentech
Read More
Researchers in Japan disclose humanized anti-HMGB1 MAbs
Read More
FDA grants Insys Therapeutics' cannabidiol orphan drug designation for GBM
Read More
Advaxis and Merck & Co. to collaborate on cancer immunotherapy combination trial
Read More
Nuvilex's cancer treatment evaluated in preclinical studies for malignant ascites
Read More
Enrollment open in phase I study of CB-5083 for relapsed/refractory multiple myeloma
Read More
Stanford University begins first-in-human study of Hu5F9-G4 for solid tumors
Read More
Vertex patents novel Na channel modulators
Read More
Naurex designs a new series of NMDA receptor modulators
Read More
DeuteRx divulges new deuterated PPAR-gamma agonists
Read More
Latuda launched in the U.K. for schizophrenia
Read More
Phase III REGULATE-PCI of Revolixys Kit halted
Read More